Results 261 to 270 of about 102,446 (342)

Evolution and Biometry*

open access: yesBiometrics, 1999
openaire   +1 more source

Causal Effects of Hydrophilic Bile Acids on Carfilzomib‐Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Carfilzomib is highly effective in the treatment of multiple myeloma, but it has been associated with cardiovascular adverse events that impact patient outcomes. Our prior global metabolomic analyses indicated an association between hydrophilic bile acids and carfilzomib‐cardiotoxicity risk, although a causal relationship remained to be determined ...
Samia Shabnaz   +15 more
wiley   +1 more source

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld   +9 more
wiley   +1 more source

Late gestation MRI to assess maternal pelvimetry, fetal biometry and placental oxygenation: a retrospective pilot study. [PDF]

open access: yesBMC Pregnancy Childbirth
Jaufuraully S   +8 more
europepmc   +1 more source

Correction: Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomes. [PDF]

open access: yesFront Digit Health
Crispo A   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy